Pharmaceutical LSD (MM120) Shows Promise in Treating Generalized Anxiety Disorder in UCSF Clinical Trials
By
carlos-menezes
Warm and crisp on the edges. A bagel with a bit of bite.
Summary
Researchers at UCSF are testing MM120, a pharmaceutical form of LSD, as a treatment for generalized anxiety disorder (GAD). The treatment has shown promising results in clinical trials, with a single dose significantly outperforming standard medications by promoting neuroplasticity and easing rigid thought patterns. The research offers hope for the roughly 5% of U.S. adults with GAD who often find little relief from traditional treatments.
Key quotes
· 4 pulledRoughly one in twenty adults in the United States lives with generalized anxiety disorder (GAD).
At UCSF, neuroscientist Jennifer Mitchell is testing a pharmaceutical form of LSD called MM120, which has shown striking results in reducing symptoms by promoting neuroplasticity and easing rigid thought patterns.
In clinical trials, a single dose significantly outperformed standard treatments, offering hope to those who have found little relief elsewhere.
Many avoid leaving home, struggle to maintain employment, and find it difficult to build meaningful social connections.
You might also wanna read
Creatine supplement shows cognitive benefits: slows early Alzheimer's decline by 30% and improves mental performance, studies find
A comprehensive review (2025) and clinical trial (2026) reveal that creatine, widely used as a muscle-building supplement, also crosses the
thesciverse.org·18h ago
Japanese researchers develop vitamin K-like compounds that may help convert brain cells into neurons
Japanese researchers have developed a new family of vitamin K-like molecules that may help immature brain cells transition into neurons. Whi
zmescience.com·1d ago
Gladstone Scientists Develop New Tool to Map Brain Waste Clearance Mechanisms
Gladstone scientists have developed a new tool to trace how the brain clears waste, revealing surprising new biology about the brain's self-
gladstone.org·2d ago
Karolinska Institutet study finds SSRIs affect developing nerve cell metabolism differently
A new study from Karolinska Institutet reveals that different SSRI medications affect metabolic processes in developing nerve cells in disti
news.ki.se·4d ago
2026 Regeneron ISEF finalists apply biochemistry and AI to address the mental health crisis
This article highlights how 2026 Regeneron ISEF finalists are using biochemistry, AI, and medical research to develop solutions for the ment
societyforscience.org·4d ago
Large longitudinal study examines delayed cortical thinning as biomarker for attention problems, highlighting sex differences in youth
This study examines whether delayed age-related cortical thinning is a reliable biomarker for attention problems and ADHD in youth. Using a
pnas.org·4d ago